6/3
08:05 am
apvo
Aptevo Participating in the BIO International Convention
Medium
Report
Aptevo Participating in the BIO International Convention
6/3
02:29 am
apvo
Alligator Bioscience's Phase 2 mitazalimab Pancreatic Cancer Data Published in The Lancet Oncology [Yahoo! Finance]
Medium
Report
Alligator Bioscience's Phase 2 mitazalimab Pancreatic Cancer Data Published in The Lancet Oncology [Yahoo! Finance]
5/23
05:31 pm
apvo
Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting [Yahoo! Finance]
Low
Report
Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting [Yahoo! Finance]
5/14
08:15 am
apvo
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA [Yahoo! Finance]
Low
Report
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA [Yahoo! Finance]
5/14
08:05 am
apvo
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
Medium
Report
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
5/8
08:05 am
apvo
Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update
High
Report
Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update
4/18
02:03 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/16
02:14 pm
apvo
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why [Yahoo! Finance]
Low
Report
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why [Yahoo! Finance]
4/15
04:23 pm
apvo
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering [Yahoo! Finance]
Low
Report
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering [Yahoo! Finance]
4/15
04:05 pm
apvo
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
Low
Report
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
4/10
09:15 am
apvo
Aptevo Therapeutics Provides Pipeline Update [Yahoo! Finance]
High
Report
Aptevo Therapeutics Provides Pipeline Update [Yahoo! Finance]
4/10
09:00 am
apvo
Aptevo Therapeutics Provides Pipeline Update
High
Report
Aptevo Therapeutics Provides Pipeline Update
4/10
02:03 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
4/2
02:05 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/25
02:06 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.